Anti-TRIM38 monoclonal antibody

Pre-made anti-TRIM38 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TRIM38/TRIM38 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2778-Ab-1/ GM-Tg-hg-IP2778-Ab-2Anti-Human TRIM38 monoclonal antibodyHuman
GM-Tg-rg-IP2778-Ab-1/ GM-Tg-rg-IP2778-Ab-2Anti-Rat TRIM38 monoclonal antibodyRat
GM-Tg-mg-IP2778-Ab-1/ GM-Tg-mg-IP2778-Ab-2Anti-Mouse TRIM38 monoclonal antibodyMouse
GM-Tg-cynog-IP2778-Ab-1/ GM-Tg-cynog-IP2778-Ab-2Anti-Cynomolgus/ Rhesus macaque TRIM38 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2778-Ab-1/ GM-Tg-felg-IP2778-Ab-2Anti-Feline TRIM38 monoclonal antibodyFeline
GM-Tg-cang-IP2778-Ab-1/ GM-Tg-cang-IP2778-Ab-2Anti-Canine TRIM38 monoclonal antibodyCanine
GM-Tg-bovg-IP2778-Ab-1/ GM-Tg-bovg-IP2778-Ab-2Anti-Bovine TRIM38 monoclonal antibodyBovine
GM-Tg-equg-IP2778-Ab-1/ GM-Tg-equg-IP2778-Ab-2Anti-Equine TRIM38 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2778-Ab-1/ GM-Tg-hg-IP2778-Ab-2; GM-Tg-rg-IP2778-Ab-1/ GM-Tg-rg-IP2778-Ab-2;
GM-Tg-mg-IP2778-Ab-1/ GM-Tg-mg-IP2778-Ab-2; GM-Tg-cynog-IP2778-Ab-1/ GM-Tg-cynog-IP2778-Ab-2;
GM-Tg-felg-IP2778-Ab-1/ GM-Tg-felg-IP2778-Ab-2; GM-Tg-cang-IP2778-Ab-1/ GM-Tg-cang-IP2778-Ab-2;
GM-Tg-bovg-IP2778-Ab-1/ GM-Tg-bovg-IP2778-Ab-2; GM-Tg-equg-IP2778-Ab-1/ GM-Tg-equg-IP2778-Ab-2
Products NameAnti-TRIM38 monoclonal antibody
Formatmab
Target NameTRIM38
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TRIM38 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2778-Ag-1Recombinant multi-species TRI38/ TRIM38/ RNF15 protein
    ORF Viral VectorpGMLPm001362mouse Trim38 Lentivirus plasmid
    ORF Viral VectorvGMLPm001362mouse Trim38 Lentivirus particle


    Target information

    Target IDGM-IP2778
    Target NameTRIM38
    Gene ID10475,214158,680019,694861,488257,101085464,531022,100052917
    Gene Symbol and SynonymsGm23,RNF15,RORET,TRIM38
    Uniprot AccessionO00635,Q58DK8
    Uniprot Entry NameTRI38_HUMAN,TRI38_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112343
    Target ClassificationN/A

    The target: TRIM38, gene name: TRIM38, also named as RNF15, RORET. This gene encodes a member of the tripartite motif (TRIM) family. The encoded protein contains a RING-type zinc finger, B box-type zinc finger and SPRY domain. The function of this protein has not been identified. A pseudogene of this gene is located on the long arm of chromosome 4. [provided by RefSeq, Jul 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.